✦ LIBER ✦

Crizotinib: A Review of Its Use in the Treatment of Anaplastic Lymphoma Kinase-Positive, Advanced Non-Small Cell Lung Cancer

✍ Scribed by Frampton, James E.

Book ID: 121394379
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 517 KB
Volume: 73
Category: Article
ISSN: 0012-6667
DOI: 10.1007/s40265-013-0142-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Crizotinib: a guide to its use in previo

Crizotinib: a guide to its use in previously treated advanced anaplastic lymphoma kinase-positive non-small cell lung cancer in the EU

✍ Hines, Mary; Lyseng-Williamson, Katherine A.; Curran, Monique P. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 229 KB

U.S. Food and Drug Administration Approv

U.S. Food and Drug Administration Approval: Crizotinib for Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer That Is Anaplastic Lymphoma Kinase Positive

✍ Malik, S. M.; Maher, V. E.; Bijwaard, K. E.; Becker, R. L.; Zhang, L.; Tang, S. 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 433 KB

369 Timing of responses to crizotinib (P

369 Timing of responses to crizotinib (PF-02341066) in anaplastic lymphoma kinase (ALK)-positive patients with advanced non-small cell lung cancer (NSCLC)

✍ B. Solomon; Y.J. Bang; D.R. Camidge; A.J. Iafrate; E.L. Kwak; R.G. Maki; S.I. Ou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Favorable clinical outcomes of pemetrexe

Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer

✍ Lee, Ha Yeon; Ahn, Hee Kyung; Jeong, Ji Yun; Kwon, Mi Jung; Han, Jung-Ho; Sun, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 533 KB

Diagnostic assays for identification of

Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer

✍ Weickhardt, Andrew J.; Aisner, Dara L.; Franklin, Wilbur A.; Varella-Garcia, Mar 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Cost Effectiveness of Crizotinib for Ana

Cost Effectiveness of Crizotinib for Anaplastic Lymphoma Kinase-Positive, Non-Small-Cell Lung Cancer: Who Is Going to Blink at the Cost?

✍ Kelly, R. J.; Hillner, B. E.; Smith, T. J. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 59 KB